Comparison of point-of-care HbA 1c test versus standardized laboratory testing

Annals of Pharmacotherapy

Volumn 39, Issue 6, 2005, Pages 1024-1028

  Sicard, Devin A ^a   Taylor, James R ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Diabetes; Hemoglobin A 1c; Point of care

Indexed keywords

HEMOGLOBIN A1C;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOGLOBIN ANALYSIS; HOSPITAL INFORMATION SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LABORATORY TEST; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

BLOOD GLUCOSE SELF-MONITORING; CLINICAL LABORATORY TECHNIQUES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS;

EID: 18844430593     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E504     Document Type: Article

References (15)

1. American Diabetes Association, www.diabetes.org (accessed 2004 Jun 24).
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27(suppl 1):15-35.
3. American Association of Clinical Endocrinologists and the American College of Endocrinology. Medical guidelines for the management of diabetes mellitus. Endocrine Pract 2002;8(suppl 1):41-82.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
5. The United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
6. Action to control cardiovascular risk in diabetes, www.accordtrial.org (accessed 2004 May 30).
7. 1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999;22:1785-9.
8. Flexsite Diagnostics, www.flexsite.com (accessed 2004 Jun 25).
9. Diabetes Technologies. www.diabetestechnologies.com (accessed 2004 Mar 1).
10. Bayer Diagnostics. www.bayerdiag.com/products_detail.cfm?id = 66 (accessed 2004 Jun 24).
11. Package insert. DCA 2000. Elkhart, IN: Bayer Corporation, June 2003.
12. Ebiosafe. www.ebiosafe.com (accessed 2004 Jun 25).
13. Product insert. A1c Now. Sunnyvale, CA: Metrika, June 2003.
14. Metrika: A1c Now. www.A1cNow.com (accessed 2004 Jun 24).
15. National Glycohemoglobin Standardization Program (NGSP). http://web.missouri.edu/~diabetes/ngsp.html (accessed 2004 Jun 25).